Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Emmanuel Macron
International Yoga Day
United States of America
Pride Month
COVID-19
Mark Cuban
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / World News / FDA rejects emergency-use approval of Bharat Biotech's COVAXIN
World

FDA rejects emergency-use approval of Bharat Biotech's COVAXIN

FDA rejects emergency-use approval of Bharat Biotech's COVAXIN
Written by Sagar
Jun 11, 2021, 02:22 pm 3 min read
FDA rejects emergency-use approval of Bharat Biotech's COVAXIN
The US FDA has rejected Bharat Biotech's application for an emergency use authorization for COVAXIN.

The United States' top drug regulator - the Food and Drug Administration - has rejected Bharat Biotech's application for an emergency use authorization for its COVID-19 vaccine COVAXIN. The authorities have asked for additional information and data for the vaccine, effectively delaying its potential launch in the US. Bharat Biotech's partner in the US says it would now seek a full approval.

Details
Company says it would now apply for a full approval

The FDA has rejected the approval request as Bharat Biotech had submitted partial trial data from March this year, and data from an additional clinical trial would be required, according to Hindustan Times. Ocugen, Bharat Biotech's partner in the US, said it would skip the emergency use authorization and instead apply for a Biological License Application (BLA) or full approval at a later time.

Quote
'Committed to bringing COVAXIN to the US'

"The FDA provided feedback to Ocugen regarding the Master File submitted previously and recommended that we pursue a BLA submission instead of an EUA application for the vaccine candidate and requested additional information and data," Ocugen said in a statement to the New York Stock Exchange. "While this will extend our timelines, we're committed to bringing COVAXIN to the US," the company's CEO said.

Vaccine
COVAXIN is 78% effective against symptomatic disease

COVAXIN is India's only approved indigenous coronavirus vaccine. It is currently one of the three vaccines being used in India's nationwide inoculation program, that began in January. As per an interim analysis, the vaccine was found to be 78% effective against symptomatic COVID-19 disease and 100% effective in providing protection from serious illness.

Phase-3 data
COVAXIN has not furnished phase-3 trial data yet

The rejection from the US health officials comes at a time when Bharat Biotech is facing criticism in India for failing to share its phase-3 trial data even six months after the vaccine was granted emergency use approval in India. In January, the company had said it would submit results by March, but recently stated the data would be made public only in July.

Recognition
Many countries do not yet recognize COVAXIN

COVAXIN has been facing troubles securing approvals in foreign countries and from the World Health Organization (WHO). International recognition is essential for the company to start widely exporting its vaccine and become part of the "vaccine passport" - under which fully vaccinated people would be allowed to travel abroad. Countries that have approved the jab include Iran, Philippines, Mauritius, Mexico, Nepal, Guyana, and Zimbabwe.

Information
US universities ask students who took COVAXIN to get re-vaccinated

In fact, universities across the US are asking foreign students to get re-vaccinated if they have been inoculated with vaccines that don't yet have the approval from the WHO. This includes Indian students who may have taken COVAXIN or the Russian vaccine Sputnik V's shots.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
Food and Drug Administration
Coronavirus
COVAXIN
Related
Latest
CCM Classic Tracker introduced in two variants: Check prices
CCM Classic Tracker introduced in two variants: Check prices Auto
Looking at 'Taarak Mehta Ka Ooltah Chashmah's cast members' earnings
Looking at 'Taarak Mehta Ka Ooltah Chashmah's cast members' earnings Entertainment
ENG vs IND, Edgbaston Test: Records which can be scripted
ENG vs IND, Edgbaston Test: Records which can be scripted Sports
Caroline Garcia beats Bianca Andreescu to win Bad Homburg Open
Caroline Garcia beats Bianca Andreescu to win Bad Homburg Open Sports
Ranji Trophy final: Madhya Pradesh take charge on Day 4
Ranji Trophy final: Madhya Pradesh take charge on Day 4 Sports
Food and Drug Administration
Pfizer pill cuts risk of severe COVID-19 by 89%
Pfizer pill cuts risk of severe COVID-19 by 89% World
Onion-linked salmonella: US FDA launches probe as hundreds fall ill
Onion-linked salmonella: US FDA launches probe as hundreds fall ill World
US allows entry to fully vaccinated adults. Can Indians travel?
US allows entry to fully vaccinated adults. Can Indians travel? India
Impossible Foods launches chicken-less chicken nuggets in restaurants in US
Impossible Foods launches chicken-less chicken nuggets in restaurants in US Technology
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
More News
Coronavirus
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
COVID-19: India logs 7,584 fresh cases, 24 more fatalities
COVID-19: India logs 7,584 fresh cases, 24 more fatalities India
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
More News
Related
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers World
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
India's drug regulator approves study on mixing Covishield, COVAXIN jabs
India's drug regulator approves study on mixing Covishield, COVAXIN jabs India
Next News Article
Next News Article

Love World news?

Subscribe to stay updated.

World Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022